VanEck Associates’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.42M | Buy |
50,501
+1,081
| +2% | +$116K | 0.01% | 697 |
|
2025
Q1 | $4.99M | Sell |
49,420
-9,564
| -16% | -$965K | 0.01% | 713 |
|
2024
Q4 | $5.27M | Buy |
58,984
+1,090
| +2% | +$97.4K | 0.01% | 677 |
|
2024
Q3 | $5.06M | Buy |
57,894
+8,882
| +18% | +$777K | 0.01% | 639 |
|
2024
Q2 | $3.77M | Buy |
49,012
+2,541
| +5% | +$196K | 0.01% | 685 |
|
2024
Q1 | $3.18M | Sell |
46,471
-5,934
| -11% | -$406K | ﹤0.01% | 727 |
|
2023
Q4 | $3.03M | Buy |
52,405
+1,659
| +3% | +$95.9K | 0.01% | 681 |
|
2023
Q3 | $2.68M | Sell |
50,746
-1,435
| -3% | -$75.8K | 0.01% | 673 |
|
2023
Q2 | $2.82M | Sell |
52,181
-254
| -0.5% | -$13.7K | 0.01% | 646 |
|
2023
Q1 | $2.62M | Sell |
52,435
-2,752
| -5% | -$138K | 0.01% | 632 |
|
2022
Q4 | $2.55M | Buy |
55,187
+1,692
| +3% | +$78.3K | 0.01% | 622 |
|
2022
Q3 | $2.07M | Buy |
53,495
+4,910
| +10% | +$190K | 0.01% | 637 |
|
2022
Q2 | $1.81M | Buy |
48,585
+1,966
| +4% | +$73.3K | ﹤0.01% | 679 |
|
2022
Q1 | $2.07M | Sell |
46,619
-3,247
| -7% | -$144K | ﹤0.01% | 698 |
|
2021
Q4 | $2.12M | Buy |
49,866
+32,844
| +193% | +$1.4M | ﹤0.01% | 707 |
|
2021
Q3 | $739K | Buy |
17,022
+1,262
| +8% | +$54.8K | ﹤0.01% | 865 |
|
2021
Q2 | $674K | Sell |
15,760
-24
| -0.2% | -$1.03K | ﹤0.01% | 870 |
|
2021
Q1 | $610K | Buy |
15,784
+3,887
| +33% | +$150K | ﹤0.01% | 823 |
|
2020
Q4 | $428K | Hold |
11,897
| – | – | ﹤0.01% | 791 |
|
2020
Q3 | $455K | Sell |
11,897
-513
| -4% | -$19.6K | ﹤0.01% | 751 |
|
2020
Q2 | $436K | Sell |
12,410
-7,388
| -37% | -$260K | ﹤0.01% | 737 |
|
2020
Q1 | $646K | Sell |
19,798
-17,349
| -47% | -$566K | ﹤0.01% | 648 |
|
2019
Q4 | $1.68M | Buy |
37,147
+1,513
| +4% | +$68.4K | 0.01% | 543 |
|
2019
Q3 | $1.45M | Buy |
35,634
+2,984
| +9% | +$121K | 0.01% | 525 |
|
2019
Q2 | $1.4M | Buy |
32,650
+15,568
| +91% | +$669K | 0.01% | 522 |
|
2019
Q1 | $656K | Buy |
+17,082
| New | +$656K | ﹤0.01% | 648 |
|